Literature DB >> 18680391

Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.

Dingzhi Huang1, Quanli Gao, Liping Guo, Chunpeng Zhang, Wei Jiang, Hongxia Li, Jing Wang, Xiaohong Han, Yuankai Shi, Shih Hsin Lu.   

Abstract

Side population (SP) cells may play an important role in tumorigenesis and cancer therapy. We isolate and identify the cancer stem-like cells in human esophageal carcinoma (EC) cell lines, EC9706 and EC109 cells labeled with Hoechst 33342. Both the cell lines contained SP cells, and the cells that had the strongest dye efflux activity ("Tip"-SP cell) in EC9706 had higher clone formation efficiency than non-SP cells. When transplanted into nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, "Tip"-SP cells showed at least 50 times higher tumorigenicity than non-SP cells. Microarray analysis discriminated a differential gene expression profile between "Tip"-SP and non-SP cells, which is further tested using quantitative real-time RT-PCR. It is ascertained that several important stem cell-related genes (including OCT-4, SOX-2, BMI-1, and ZFX), two ATP-binding cassette (ABC) transporter genes (ABCG2 and ABCA5), and three Wnt and two Notch signal pathway-related genes (such as FZD10, PTGS2, KLF5, TTK, and RBM15) were upregulated in "Tip"-SP cells. Western blot showed a higher expression of beta-catenin protein in "Tip"-SP cells. All these indicated that the minority population described as "Tip"-SP cells possessed cancer stem cell character. Further understanding of tumor stem cell-specific traits will offer insights on the early stages of tumorigenesis for prevention and enhanced selectivity of antitumor therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680391     DOI: 10.1089/scd.2008.0033

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  77 in total

Review 1.  Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Aspects Med       Date:  2013-08-29

Review 2.  New promising drug targets in cancer- and metastasis-initiating cells.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2010-03-23       Impact factor: 7.851

Review 3.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

4.  Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.

Authors:  Dan Rudin; Liang Li; Nifang Niu; Krishna R Kalari; Judith A Gilbert; Matthew M Ames; Liewei Wang
Journal:  J Drug Metab Toxicol       Date:  2011-02-02

5.  Not all side population cells contain cancer stem-like cells in human gastric cancer cell lines.

Authors:  Haihong Zhang; Hongqing Xi; Aizhen Cai; Qijun Xia; Xin Xin Wang; Canrong Lu; Yong Zhang; Zhou Song; Hua Wang; Qinfang Li; Lin Chen; Zikuan Guo
Journal:  Dig Dis Sci       Date:  2012-08-10       Impact factor: 3.199

Review 6.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

7.  ZFX regulates glioma cell proliferation and survival in vitro and in vivo.

Authors:  Zhichuan Zhu; Kui Li; Dafeng Xu; Yongjie Liu; Hailiang Tang; Qing Xie; Liqian Xie; Jiwei Liu; Hongtao Wang; Ye Gong; Zelan Hu; Jing Zheng
Journal:  J Neurooncol       Date:  2013-01-16       Impact factor: 4.130

Review 8.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

9.  Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs.

Authors:  Masakazu Kamata; Min Liang; Shirley Liu; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

10.  TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.

Authors:  M R Loebinger; E K Sage; D Davies; S M Janes
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.